[Hemodynamic basis of antianginal effect of calcium antagonists in patients with ischemic heart disease after aortocoronary shunting: myocardial reserve potentials and their mechanisms].
Knyshov
G V
GV
Vykhovaniuk
I V
IV
Tkhor
N V
NV
Furkalo
S N
SN
Korchinskaia
O I
OI
D000328:Adult; D000787:Angina Pectoris / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D001026:Coronary Artery Bypass; D004305:Dose-Response Relationship, Drug; D005080:Exercise Test; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000503:physiopathology / Q000601:surgery*; D009543:Nifedipine / Q000494:pharmacology / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D015635:Radionuclide Ventriculography; D013670:Sodium Pertechnetate Tc 99m; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use*
D013670:Sodium Pertechnetate Tc 99m; D014700:Verapamil; D009543:Nifedipine
Gemodinamicheskoe obosnovanie antianginalńogo éffecta antagonistov kaltsiia u bolńykh ishemicheskoĭ bolezníu cerdtsa posle operatsii aortokoronarnogo shuntirovaniia: rezervnye vozmozhnosti miokarda i mekhanizmy ikh realizatsii.